16
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Positive Bubble Study in Severe COVID-19: Bubbles May Be Unrelated to Gas Exchange Impairment

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To the Editor: Data obtained using the multiple inert gas elimination technique show that hypoxemia in acute respiratory distress syndrome arises from regions with shunt and/or low V ˙ / Q ˙ mismatch (1) but, more importantly, show no diffusion limitation of oxygen uptake into the pulmonary capillaries. Hypoxemia in patients with coronavirus disease (COVID-19)–associated lung disease may also be reasonably believed to result from V . / Q . mismatch and shunt, but this has not been tested by definitive means. With this as brief background, we read the interesting study by Reynolds and colleagues (2), who used contrast-enhanced transcranial Doppler (TCD) after injection of agitated saline to detect transpulmonary transit of microbubbles as evidence for pulmonary microvascular dilatations in patients with severe COVID-19, a finding noted at autopsy (3). The authors made three key observations: 1) 83% of patients had detectable microbubbles with a median of 8 detected, 2) the PaO2 /Fi O2 was inversely correlated with the number of microbubbles, and 3) the number of microbubbles was inversely correlated to lung compliance. On the basis of their findings, they suggest that these pulmonary microvascular dilatations may explain the disproportionate degree of hypoxemia in some patients with COVID-19–associated lung injury akin to the perfusion–diffusion limitation for oxygen uptake occurring in the greatly enlarged pulmonary microvascular dilations of hepatopulmonary syndrome, as discussed in the accompanying editorial by DuBrock and Krowka (4). We find several problems with the interpretation of these results. First, patent foramen ovale (PFO) is rather common, and because PFO presence was not examined in this study, we cannot rule out this as a contribution to their TCD microbubble detection. It would have been useful for the investigators to have performed TCD in patients with equally severe acute respiratory distress syndrome as a control group to detect whether the two conditions differ in this regard with their methodology. Second, the issue is not one of TCD sensitivity to detect microbubbles (5) but rather whether the microbubbles represent a cause of meaningful gas exchange derangement. For example, Stickland and colleagues (6) studied animals without PFO with a similar amount of bubble transit on transthoracic echocardiography, which are a result of naturally occurring intrapulmonary arterial–venous anastomoses. Despite a large amount of bubble contrast traversing the pulmonary circulation and appearing in the left ventricle, there was no evidence for a diffusion limitation of oxygen, and the actual shunt quantified by both 25 μm microspheres and the multiple inert gas elimination technique was small (<1.5% of Q̇). These data also showed that, although contrast echocardiography is extremely sensitive, it is nonspecific and frequently detects very small anatomical shunts that are <1% of Q̇ and of trivial importance for gas exchange. Consequently, the nonquantitative nature of transthoracic echocardiography and/or TCD does not permit any conclusions as to whether hypoxemia is caused by the putative microvascular dilatations described by Ackermann and colleagues (3) and others. Although the autopsy data show congested capillaries and slightly increased diameters, any comparison with the far greater vessel dilation (up to 100 μm) and the perfusion–diffusion limitation in hepatopulmonary syndrome is tenuous (4). It is more likely that the correlations of the TCD bubble score with compliance and the severity of hypoxemia as assessed by the PaO2 /Fi O2 simply reflect the amount of lung involvement with shunt and low V . / Q . ratios, with TCD bubble detection from a PFO and/or recruitment of intrapulmonary arterial–venous anastomoses because of hypoxia, higher Q̇, and/or increased pulmonary artery pressure (6).

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

          Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of the disease, relatively little is known about the associated morphologic and molecular changes in the peripheral lung of patients who die from Covid-19.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Pulmonary Vascular Dilatation Detected by Automated Transcranial Doppler in COVID-19 Pneumonia

            To the Editor: Some patients with coronavirus disease (COVID-19) pneumonia demonstrate severe hypoxemia despite having near normal lung compliance, a combination not commonly seen in typical acute respiratory distress syndrome (ARDS) (1). The disconnect between gas exchange and lung mechanics in COVID-19 pneumonia has raised the question of whether the mechanisms of hypoxemia in COVID-19 pneumonia differ from those in classical ARDS. Dual-energy computed tomographic imaging has demonstrated pulmonary vessel dilatation (2) and autopsies have shown pulmonary capillary deformation (3) in patients with COVID-19 pneumonia. Contrast-enhanced transcranial Doppler (TCD) of the bilateral middle cerebral arteries after the injection of agitated saline is an ultrasound technique, similar to transthoracic or transesophageal echocardiography, that can be performed to detect microbubbles and diagnose intracardiac or intrapulmonary shunt (Figure 1) (4, 5). TCD is more sensitive than transthoracic echocardiography in detecting right-to-left shunt, (6) and it is less invasive than transesophageal echocardiography. We performed a cross-sectional pilot study of TCD (Lucid Robotic System; NovaSignal Corp) in all mechanically ventilated patients with severe COVID-19 pneumonia from two COVID-19 ICUs who were not undergoing continuous renal replacement therapy or extracorporeal membrane oxygenation (N = 18). This study was approved by the Mount Sinai Institutional Review Board (approval 20–03660). Agitated saline was injected through either a peripheral intravenous line in the upper extremity or a central line in the internal jugular vein. The system software automatically counted the number of microbubbles detected over 20 seconds; as a quality control measure, we manually counted and confirmed the number of microbubbles and were blinded to the patients’ clinical condition and PaO2 :Fi O2 ratio. Sixty-one percent (n = 11) of patients were men. Patients had a median age of 59 years (interquartile range, 54–68 years), with a PaO2 :Fi O2 ratio of 127 mm Hg (interquartile range, 94–173 mm Hg). Lung compliance was measured in 16 patients and was low (median 22 ml/cm H2O; interquartile range 15–34 ml/cm H2O). None of the patients had a known history of chronic liver disease or preexisting intracardiac shunt. Contrast-enhanced TCD detected a median of 8 microbubbles (interquartile range, 1–22; range 0–300). Three major findings from contrast-enhanced TCD were observed. First, 15 of 18 (83%) patients had detectable microbubbles (see Figure 1 for representative images). Second, the PaO2 :Fi O2 ratio was inversely correlated with the number of microbubbles (Pearson’s r = −0.55; P = 0.02) (Figure 2A). Third, the number of microbubbles was inversely correlated to lung compliance (Pearson’s r = −0.61; P = 0.01) (Figure 2B). Figure 1. Assessment of microbubbles by transcranial Doppler (TCD) after injection of agitated saline. Representative images were captured during TCD evaluation after injection of agitated saline. (A and B) Continuous spectral waveforms of the middle cerebral artery (MCA) during insonation over 5 seconds. C and D demonstrate the power M-mode, and positive microbubbles appear as vertical lines (arrows). (A and C) Images from the left MCA of a 60-year-old woman in whom TCD detected five microbubbles. (B and D) Images from the right MCA of a 69-year-old man in whom TCD detected 300 microbubbles. His PaO2 :Fi O2 ratio was 55 mm Hg, which was the lowest in the cohort. Figure 2. Associations between number of microbubbles and PaO2 :Fi O2 ratio and lung compliance. (A) A scatterplot of the log-transformed number of microbubbles as detected by transcranial Doppler and PaO2 :Fi O2 ratio (r = −0.55; P = 0.02) and suggests that the number of microbubbles increases with declining PaO2 :Fi O2 ratio. (B) A scatterplot of the log-transformed number of microbubbles as detected by transcranial Doppler and lung compliance (r = −0.61; P = 0.01) and suggests that the number of microbubbles increases with declining lung compliance. These data suggest that pulmonary vasodilatations may explain the disproportionate hypoxemia in some patients with COVID-19 pneumonia and, somewhat surprisingly, track with poor lung compliance (1). Our detection of transpulmonary bubbles may be analogous to hepatopulmonary syndrome, a pulmonary vascular disorder of chronic liver disease characterized by pulmonary vascular dilatations with increased blood flow to affected lung units, which results in ventilation–perfusion mismatch and hypoxemia (4). The normal lung filters microbubbles from the injection of agitated saline as the bubble diameter is larger (smallest bubble approximately 24 μm in diameter [5]) than the normal pulmonary capillary (<15 μm in diameter [7]). In hepatopulmonary syndrome, and similar to what we observed in this pilot study, the presence and degree of transpulmonary bubble transit correlate with the degree of hypoxemia (8). Although we cannot rule out intracardiac shunt as a cause of observed microbubbles, we note that the prevalence of transpulmonary bubbles seen in our study is markedly higher than the prevalence of patent foramen ovales seen in the general population (9). In a prior study of 265 patients with ARDS receiving mechanical ventilation, only 42 patients (16%) were found to have patent foramen ovale as assessed by contrast transesophageal echocardiography (10). Hypoxemia in ARDS is predominantly caused by right-to-left shunt, in which systemic venous blood flows to lung regions with collapsed and/or flooded alveoli and does not get oxygenated as it passes through the lung (11). Transpulmonary bubble transit has been detected in 26% of patients with classical ARDS, although neither their presence nor their severity correlates with oxygenation (10), implying that pulmonary vascular dilatations are not a major mechanism of hypoxemia in typical ARDS. In order for transpulmonary bubble transit to occur, pulmonary vascular dilatations or pulmonary arteriovenous malformations must be present; a lack of hypoxic vasoconstriction is not sufficient. Although these observations are preliminary, the correlation seen here between the degree of transpulmonary bubble transit and PaO2 :Fi O2 ratio suggests that pulmonary vascular dilatation may be a significant cause of hypoxemia in patients with COVID-19 respiratory failure. Interestingly, patients with worse lung compliance demonstrated more microbubbles, which suggests that pulmonary vascular dilatation may worsen in parallel with the typical diffuse alveolar damage of ARDS. Our understanding of the pathophysiology of hypoxemic respiratory in COVID-19 is limited. Although a larger, confirmatory study is needed, these data, in conjunction with recent radiographic and autopsy findings, seem to implicate pulmonary vascular dilatation as a cause of hypoxemia in patients with COVID-19 pneumonia.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis.

              Patent foramen ovale (PFO) can be detected in up to 43% of patients with cryptogenic cerebral ischemia undergoing investigation with transesophageal echocardiography (TEE). The diagnostic value of transthoracic echocardiography (TTE) in the detection of PFO in patients with cryptogenic ischemic stroke or transient ischemic attack has not been compared with that of transcranial Doppler (TCD) using a comprehensive meta-analytical approach.
                Bookmark

                Author and article information

                Journal
                Am J Respir Crit Care Med
                Am J Respir Crit Care Med
                ajrccm
                American Journal of Respiratory and Critical Care Medicine
                American Thoracic Society
                1073-449X
                1535-4970
                1 February 2021
                1 February 2021
                1 February 2021
                1 February 2021
                : 203
                : 3
                : 389-390
                Affiliations
                [ 1 ]Veterans Affairs Puget Sound Healthcare System

                Seattle, Washington
                [ 2 ]University of California, San Diego

                La Jolla, California

                and
                [ 3 ]Alberta Health Services

                Edmonton, Alberta, Canada
                Author notes
                [* ]Corresponding author (e-mail: eswenson@ 123456uw.edu ).
                Author information
                http://orcid.org/0000-0002-4117-6198
                Article
                202010-3800LE
                10.1164/rccm.202010-3800LE
                7874323
                33207121
                f8cf90d7-98b9-4bda-8407-a7112dd3e5b1
                Copyright © 2021 by the American Thoracic Society

                This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 ( http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern ( dgern@ 123456thoracic.org ).

                History
                Page count
                Figures: 0, Tables: 0, Pages: 2
                Categories
                Correspondence

                Comments

                Comment on this article